1,721,662 research outputs found
The greenhouse gas balance of Italy: an insight on managed and natural terrestrial ecosystems
Biodegradable plates and screws in Ankle Fractures: our experience. (A biomechanical and clinical study)
Targeting RANKL in the management of bone loss in patient with breast cancer
The receptor activator of nuclear factor-κB ligand (RANKL), its signaling receptor RANK, and its natural decoy receptor OPG are members of the tumour necrosis factor (TNF) and TNF receptor superfamily and are best known for their essential role in controlling osteoclastogen- esis. RANKL in bone has also been shown to serve as a chemoattractant for cancer cells, thus explaining the tropism of certain cancers such as breast and prostate cancer to preferentially metastasize to bone. Here, we will discuss the important role of RANKL and its possible role in the management of bone loss in patients with breast cancer
- …
